VR Adviser »

Korro Bio shares owned by VR Adviser

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by VR Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 1.0M 11.32

More positions owned by VR Adviser

Apogee Therapeutics (APGE)
Erasca (ERAS)
Oruka Therapeutics (ORKA)
Spyre Therapeutics Com New (SYRE)
Kalvista Pharmaceuticals (KALV)
Dianthus Therapeutics (DNTH)
Damora Therapeutics Com New (DMRA)
Ocular Therapeutix (OCUL)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Savara (SVRA)
Enliven Therapeutics (ELVN)
Oric Pharmaceuticals (ORIC)
Vor Biopharma Com New (VOR)
Maze Therapeatics (MAZE)

View all positions for VR Adviser

Top funds holding Korro Bio

Lynx1 Capital Management
NEA Management Company
Atlas Venture Life Science Advisors
Balyasny Asset Management
VR Adviser
Nantahala Capital Management
ADAR1 Capital Management
Susquehanna International
Vanguard Group
BlackRock
TCG Crossover Management
Siren
Vanguard Capital Management
72 Investment Holdings
Citadel Advisors

View all funds holding Korro Bio